Latest News
-
August 2022 Community News
Read NTSAD's latest e-newsletter! Sign up to receive next month's at the bottom of the home page. Read More -
Sio GM1 and GM2 Clinical Trials News
Sio terminates licensing agreement. Read the joint statement from NTSAD and fellow patient advocacy groups and foundations. Read More -
- 1
- 2
- 3
›
‹
National Tay-Sachs & Allied Diseases Association (NTSAD) leads the worldwide fight to treat and cure Tay-Sachs, Canavan, GM1, and Sandhoff diseases by driving research, forging collaboration, and fostering community. Supporting families is the center of everything we do.
- Default
- Title
- Date
- Random
